Skip to content

Granted (in shares) at other companies

CHE
ChemedCHE
$110.38K+38.8%
The Hanover Insurance Group logo
The Hanover Insurance GroupTHG
148.1K+5.5%
Genpact logo
GenpactG
0
Ondas, Inc.
 logo
Ondas, Inc. ONDS
7.4M+45.6%
TRV
Trevi Therapeutics, Inc.TRVI
3.2M+27.2%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
578.6K

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s granted (in shares)?
Trevi Therapeutics, Inc. (TRVI) reported granted (in shares) of 3.2M in Q1 2026.
How has Trevi Therapeutics, Inc.'s granted (in shares) changed year-over-year?
Trevi Therapeutics, Inc.'s granted (in shares) increased by 27.2% year-over-year, from 2.5M to 3.2M.
What does granted (in shares) mean?
The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.